According to KOBAYASHI Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.90. In 2022 the company made an earnings per share (EPS) of $1.93 a decrease over its 2021 EPS that were of $2.25.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.90 | -1.33% |
2022 | $1.93 | -14.37% |
2021 | $2.25 | -2.84% |
2020 | $2.32 | 3.31% |
2019 | $2.24 | 8.9% |
2018 | $2.06 | 14.92% |
2017 | $1.79 | |
2015 | $1.45 | 2.28% |
2014 | $1.41 | 7.77% |
2013 | $1.31 | -36.68% |
2012 | $2.07 | 49.88% |
2011 | $1.38 | -6.4% |
2010 | $1.48 | 23.13% |
2009 | $1.20 |